期刊文献+

骨关节结核的药物治疗及其进展 被引量:1

Pharmacotherapy of Osteoarticular Tuberculosis and its Progress
下载PDF
导出
摘要 骨关节结核(osteoarticular tuberculosis)是一种特异性慢性炎性病变,绝大多数是继发结核。结核杆菌通过血行或淋巴系统传播至骨关节,该病好发于血供丰富和负重大的骨质或活动较多的关节滑膜,常发病于体质虚弱及免疫低下者,其中脊柱结核发病率最高,其次为关节结核。
作者 吴灿 刘传康
出处 《儿科药学杂志》 CAS 2009年第6期56-58,共3页 Journal of Pediatric Pharmacy
  • 相关文献

参考文献16

  • 1David AS, Girish KS, Ashok KB, et al. Tuberculosis of the Musculoskeletal System [ J ]. Techniques in Orthopaedics, 2005, 20(2) : 167-178.
  • 2罗卓荆,马宏庆,陶惠人,杜俊杰,王哲(整理).全国脊柱结核治疗专题座谈会纪要[J].中华骨科杂志,2007,27(9):669-670. 被引量:35
  • 3Tuli SM. General principles of osteoarticular tuberculosis [J]. Clin Orthop Relat Res, 2002, 398: 11-19.
  • 4Ariel PM, Mario CR, Adalbert LP, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997 [ J]. N Engl J Med, 1998, 338: 1641-1649.
  • 5朱莉贞.如何正确服用抗结核药物[J].中华结核和呼吸杂志,2007,30(6):476-477. 被引量:9
  • 6Avijit H, Baisakhi L. Chemotherapy of osteoarticular tuberculosis [J]. Indian J Pharmacol, 2005, 1 (37) : 5-12.
  • 7陈孝平.外科学(八年制)[M].北京:人民卫生出版社,2005:1085.
  • 8Zulia Wang, Zhaohui Ge, Dong Wei, et al. Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae [ J ]. The Spine Journal, 2007, 7: 671-681.
  • 9Lindsay M, Leopold B, Paul N, et al. Tuberculosis and air travel: WHO guidance in the era of drug resistant TB [ J ]. Travel Med Infect Dis, 2007, 10: 4.
  • 10A Umubyeyi, L Rigoutsb, IC Shamputa, et al. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda [ J ]. International Journal of Infectious Diseases, 2008, 12 : 152- 156.

二级参考文献23

  • 1尚宁,郭天程.结核菌L型的生物学特征及临床意义[J].陕西医学杂志,1996,25(1):36-39. 被引量:5
  • 2汪万英,何杰,张世馥,姚敏,张宗新.结核菌L型感染与无反应性结核病关系的研究[J].中国微生态学杂志,1996,8(1):14-15. 被引量:8
  • 3罗聪,安洪,蒋电明,杨晓兰,叶兰,朱照静,何涣玲.超顺磁性壳聚糖质粒明胶微球骨植入体的制备及其体外特性[J].中国药科大学学报,2006,37(5):413-418. 被引量:8
  • 4戴自英.实用抗生素学[M].上海:上海人民出版社,1977.189.
  • 5Mattman L H. L Variation in mgcobacteria [J]. Am Rev Respir Dis ,1960,202 (2) :82~85.
  • 6Dorozhkova I R.Krudu V N.Popeslcu T T.Clinical value of L-forms of mycobacterium tuberculosis in patient with residual tuberculous changes in the Lungs [J]. Probl Tuberk,1990,12:5~7.
  • 7Lynn R J.Immunology of Baclerial L-form in Maddoff.s.eds.The Bacterial L-form ed [M].New York:Marcel Dekker Inc, 1986,263~276.
  • 8Crowle A J,Sbarbako J A. May MH inhibition pyrazinamide of tubercle bacilli within cultured but macrophages [J].AM Rev ReSP Dis,1986,134(5):1052~1054.
  • 9Peloquin CA, Namdar R, Singleton MD, et al. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids. Chest, 1999,115:12-18.
  • 10马锡良 张文敏 徐风铎 等.不同服药时间对利福平血药浓度的影响[J].中华结核和呼吸杂志,1988,11:55-56.

共引文献56

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部